Drug Discovery
PROTACs are revolutionizing small molecule drug development
PROTACs are driving small molecule drug development to treat cancer, neurodegenerative diseases and more
Read the CAS Insights articleKavita Iyer graduated with a Bachelor of Pharmacy from the University of Mumbai in 2011. Subsequently she earned her PhD in Medicinal Chemistry from Virginia Commonwealth University, USA. She further pursued a post-doctoral fellowship in the Department of Physiology and Biophysics at VCU where she was trained as a structural biologist and subsequently worked as a Research Scientist. Prior to joining CAS, she worked briefly at ACSII.